Introduction
In commercial agriculture, crop protection against phytopathogens relies heavily on chemical pesticides. Use of commercial fungicides offers an effective control strategy, but this approach is not only expensive but also poses adverse effects to human health and the environment and is lethal to other beneficial rhizosphere bacteria. At this juncture, environmentally friendly control of fungal pathogens is a pressing need for sustainable agriculture (1) . Biological control of soil-borne diseases by plant growth promoting rhizobacteria is a well-established phenomenon and antibiotics have been shown to play a major role in the suppression of several plant pathogens (2) .
The control of phytopathogenic fungi by biocontrol agents depends on a wide variety of traits, such as the production of antifungal metabolites and lytic enzymes, induction of systemic resistance, and high competitive maintenance in the rhizosphere, which are considered to be important prerequisites for the optimal performance of plant growth-promoting rhizobacteria (PGPR) towards plant pathogens (3) (4) (5) . Bacterial secondary metabolites play a critical role in bacterium-host interactions. Secondary metabolites produced by beneficial bacteria prevent infection by altering the environment and improving the bacterium's ability to compete with pathogens, by inhibiting the activity of pathogens, or by triggering host defenses (6, 7) .
In recent years, several plant root-colonizing Pseudomonas spp. have been shown to be a potent biocontrol agent in various plant-pathogen systems (8) . The production of antifungal secondary metabolites such as 2,4-diacetylphloroglucinol (2,4-DAPG / DAPG or Phl), pyoluteorin (PLT), hydrogen cyanide (HCN), phenazines, or pyrrolnitrin (PRN) is a prominent feature of many biocontrol fluorescent Pseudomonas spp. (9) (10) (11) .
Recently, genetic analysis of several Pseudomonas strains has also established a positive correlation between antibiotic production and disease suppression (12, 13) . However, success in the field is limited due to variable results. Isolation and characterization of the genes from microbes antagonistic to the different phytopathogens will enable us to understand the molecular mechanism involved in biological control approaches. Therefore, the present study was aimed at understanding the genes involved in antagonism to fungal pathogens so as to develop the strain Pseudomonas aeruginosa FP6 into an efficient biocontrol agent.
Materials and methods

Bacterial strain
The bacterium P. aeruginosa, isolated from rhizospheric soil samples from in and around Bangalore, was used in this study. The isolate was identified as Pseudomonas aeruginosa. The nucleotide sequence of the 16S rRNA of Pseudomonas aeruginosa FP6 was deposited in the GenBank database under the accession number JN861778.
Fungal pathogens
Rhizoctonia solani (MTCC 4233) was procured from the Microbial Type Culture Collection Centre (IMTECH, Chandigarh, India) and Colletotrichum gloeosporioides (OGC1) was kindly provided by the Indian Institute of Horticultural Research (IIHR), Bangalore. Phytopathogens were maintained on potato dextrose agar (PDA) medium.
Antagonistic activity
Antagonistic activity of P. aeruginosa FP6 was tested against R. solani and C. gloeosporioides by dual culture technique. The percentage inhibition was then calculated (14) .
P. aeruginosa was grown in King's B medium at 37 °C and 120 rpm for 48 h. The supernatant was separated by centrifugation at 11,200 × g for 10 min. Supernatant was concentrated by lyophilization and sterilized by filtration through a 0.45-µm filter (Millipore, India). Test plates were prepared by mixing 9 mL of molten PDA and 1 mL of concentrated supernatant. In an actively growing mycelial disk of 9 mm in diameter, R. solani and C. gloeosporioides were inoculated in the center of the petri plate. The plates were incubated for 5 days at 28 °C and the results were expressed as means of percentage inhibition. Plates inoculated with fungal agar plugs alone were used as the control. Similarly, the extracts of the metabolites DAPG, phenazine-1-carboxylic acid (PCA), and PLT were also checked for their antagonistic activity (15). 2.4. Sensitivity of P. aeruginosa culture supernatant to proteolytic enzymes, surfactants, heat, and pH To investigate the stability of the antifungal metabolites, concentrated crude supernatant (15 µL) of P. aeruginosa FP6 was subjected to treatments for 2 h at 37 °C (for enzymes) or room temperature (for surfactants). The proteolytic enzymes (Sigma) were used at a final concentration of 1 mg/mL in 10 mmol -1 potassium phosphate buffer, pH 7.0. The concentrated crude supernatant in buffer without enzymes as well as the enzyme solutions were exposed to the same conditions. The surfactants used were sodium dodecyl sulfate (SDS), Tween 80, and SDS and urea, at a final concentration of 1% (v ⁄v) and incubated at 37 °C for 5 h. All surfactants (Sigma) were prepared at 10% in water and filter-sterilized before use. For the heat treatment, the preparations were incubated at 25 °C or heated at 37 °C and 60 °C and autoclaved (121 °C, 15 min). For pH stability, 10 µL of concentrated supernatant was mixed with an equal volume of citric acid-Na 2 HPO 4 buffer to achieve different pH values lower than 6.0, and with Tris-HCl buffer for pH 8.0 and 10.0. Antifungal activities were checked before and after all treatments on test plates containing R. solani and percentage inhibitions were calculated. 2.5. Effect of crude supernatant on the hyphal morphology and spore germination of R. solani and C. gloeosporioides For the testing, 100 µL of spore suspensions (10 4 spores/ mL) of R. solani and C. gloeosporioides were allowed to germinate on a glass slide under high humidity in the presence of 10 µL of extract. The germination of spores was allowed at 28 °C for 24-48 h and the change in morphology was monitored microscopically.
Screening of putative antimetabolites by polymerase chain reaction
Detection of the genes that encode for the production of antibiotics such as DAPG, PCA, phenazine-1-carboxamide (PCN), PRN, and PLT was done by polymerase chain reaction (PCR) using gene-specific primers. Oligonucleotide primers were synthesized by Chromous Biotech Pvt. Ltd. (Bangalore, India). The primer sets and the amplification conditions for the screening of geneencoding antibiotics are listed in Table 1 .
Genomic DNA from P. aeruginosa FP6 was isolated using the Chromous Bacterial Genomic DNA Isolation Kit and was used in PCR analysis. The PCR reaction (50 µL) contained 50 pmol of primer, 50 ng of genomic DNA, 1X Taq DNA polymerase buffer, 0.5 U of Taq DNA polymerase, 0.2 mM of each dNTP, and 1.5 mM MgCl 2 . Amplification was performed in a DNA thermal cycler (Corbett Thermocycler). Aliquots of 10-15 µL of each amplification product were electrophoresed on a 0.8% agarose gel in 1X Tris-acetate-EDTA (TAE) buffer (40 mM Tris-acetate, 1 mM EDTA, pH 8.0) at 50 V for 1-3 h and stained with ethidium bromide, and the PCR products were visualized under a UV transilluminator. Following this, 1-kb and 5-kb ladders (Chromous Biotech Pvt. Ltd.) were used as size markers.
Plasmid curing
Curing of the plasmid from the P. aeruginosa FP6 strain was done by exposing the overnight-grown culture of P. aeruginosa to ethidium bromide (500 µg/mL). The derivatives of P. aeruginosa that were cured of the plasmid were selected on the basis of their inability to grow on the culture media supplemented with kanamycin (1000 µg/mL), unlike the parent strain, which is kanamycinresistant. The treated culture of P. aeruginosa was initially plated on a complete medium without antibiotic kanamycin. Colonies of P. aeruginosa obtained were picked and spotted on medium containing kanamycin. Colonies that were unable to grow on the medium containing kanamycin were derivatives of P. aeruginosa that were cured of the plasmid and were designated as P. aeruginosa PC 1-100. The plasmid cured strains were also screened for their antagonistic activity (dual plate culture), siderophore production (19) , HCN production (20), indole-3-acetic acid production (21) , and phosphate solubilization (22) .
Plasmid and genomic DNA isolation
The presence of plasmid in the plasmid-cured strains of P. aeruginosa PC 1 through P. aeruginosa PC 100 and the parent strain (P. aeruginosa FP6) was detected by alkaline lysis method (23) . The purified plasmid DNA was visualized by resolving on 0.8% agarose gel electrophoresis. Genomic DNA was isolated from P. aeruginosa using a genomic DNA isolation kit (Chromous Biotech Pvt. Ltd.). 2.9. Gel extraction of DNA After agarose gel electrophoresis and visualization, both genomic DNA and plasmid DNA fragments of the parent strain were excised and eluted from the gel using a gel elution kit (Chromous Biotech Pvt. Ltd.) according to the manufacturer's protocol. Eluted plasmid and genomic DNA were PCR-amplified for antifungal antimetabolites using the gene-specific primers as mentioned above.
Results and discussion
Antibiotic production by fluorescent Pseudomonas species is now recognized as an important factor in disease suppression. Performance of biocontrol microorganisms in the field is variable. Elucidation of the mechanism behind this phenomenon will contribute to defining the traits required for robust biocontrol strains and therefore enhanced performance.
In the present study P. aeruginosa significantly (P < 0.01) inhibited the growth of both R. solani (52%) and C. gloeosporioides (49%) when compared to the control by dual culture method ( Figure 1 ; Table 2 ). In dual cultures with rhizospheric bacteria, soil-borne pathogens R. solani, M. phaseolina, and S. sclerotiorum (24, 25) were reported to be inhibited. The antimicrobial activity of P. fluorescens was reported against numerous fungi (26).
3.1. Sensitivity of P. aeruginosa FP6 culture supernatant to proteolytic enzymes, surfactants, heat, and pH The cell-free culture supernatant of P. aeruginosa FP6 exhibited a maximum antifungal activity in all the treatments and was found to be highly stable at extreme pH levels and temperatures, and also after treatments with pepsin, trypsin, and different detergents (Table 3) . These results clarify the role of secondary metabolites in R. solani and C. gloeosporioides inhibition and the adaptation capability of the antagonist.
Study on hyphal morphology
Light microscope investigation revealed that the extract induced morphological abnormalities in fungal structures. It had a significant effect on spore germination and hyphal morphology after 24 h of incubation at room temperature. Sclerotial germination inhibition and immature, thin hyphae were observed in extract-treated R. solani ( Figure  2) . Swelling in the hyphal tips, slimming of hyphae, and occurrence of bubbles and vacuoles in hyphae were observed in the extract-treated C. gloeosporioides. The mycelial malformation observed was due to the toxic effect of antibiotic substances interfering with the normal growth processes (27) . P. aeruginosa is known to produce a wide range of secondary metabolites such as DAPG, PRN, and phenazine, which influence the growth and morphology of fungal mycelium (28) . Antibiotic production by P. aeruginosa has been suggested to be the mode of disease control (12, 29, 30) . The vacuolar appearance of C. gloeosporioides mycelium may be due to the antibiotic metabolites produced by the bacteria, which may penetrate and cause protoplasmic dissolution and disintegration (31).
Detection of antimetabolite genes by polymerase chain reaction
When total DNA of the strain P. aeruginosa FP6 was tested by PCR using gene-specific primers, the strain amplified the DNA fragment of 745 bp of DAPG, 1408 bp of PCA, and 438 bp of PLT (Figure 3) . The presence of secondary metabolites confirms that secondary metabolites do have a role in disease suppression. The presence of PLT and DAPG genes supports the co-occurrence of their biosynthetic pathways and is very specific only in certain group of DAPG producers (17).
Plasmid curing
In order to determine whether the antagonistic genes were located on plasmid or chromosomal DNA, plasmid curing was carried out. Antibiotic susceptibility tests of the wild strain showed sensitivity to most of the antibiotics except kanamycin (1000 µg/mL) and rifampicin (500 µg/ mL); therefore, kanamycin was used as a marker (32) . A total of 100 colonies were obtained, of which 88 colonies were able to grow on Luria-Bertani broth (LB) medium, but not on LB supplemented with kanamycin. Thus, those colonies that grew on LB were selected for further studies. The plasmid curing efficiency was 88%. When plasmid cured strains were checked for loss of antagonistic activity against R. solani and C. gloeosporioides, they showed variation in their antagonistic potential. By dual plate assay it was shown that 25 (28%) of the cured strains inhibited the growth of R. solani and C. gloeosporioides. Another 44 Results were the means of triplicates. Data were analyzed using Student's t-test.
strains (50%) showed weak antagonistic activity, i.e. the colonies were not overgrown by the fungus. The remaining 19 strains (22%) lost antagonistic property against the fungal species tested. Cured strains when further screened for other PGPR traits (indole-3-acetic acid, phosphate solubilization, siderophore, and HCN) showed no loss except the loss of phosphate solubilization efficiency. Plasmid analysis of the wild strain showed the presence of 4 bands suggesting the presence of 1 or more plasmids in this strain (Figure 4 , lane 1). Cured clones showed the loss of plasmid bands that were present in the original wild strain, which clearly demonstrates the relationship between the loss of plasmid and the loss of kanamycin resistance and phosphate solubilizing efficiency. El-Hamshary et al. showed the presence of 5 plasmids in P. aeruginosa (33) . Since our isolate showed resistance to lead and cadmium metals (data not shown), these plasmids may be coding for these genes.
Since plasmid curing studies have not conclusively proven the role of plasmid in antagonism, gene(s) located on the chromosome cannot be ruled out. Pseudomonas species are also known to harbor megaplasmids, and these plasmids have several sets of genes involved in mobilization, genes for nodulation, and biocontrol traits (34) . Furthermore, by the alkaline lysis method, when chromosomal DNA and proteins are precipitated by SDS and NaCl (5 M), megaplasmids do precipitate with them. Therefore, an alternate method was carried out to isolate the megaplasmid DNA. The preparation, however, showed the presence of only genomic DNA in both the preparations ( Figure 5 ), which also amplified the genes coding for antimetabolites, indicated by the PCR products (of expected size) that were obtained with genomic DNA preparation ( Figure 6 ) and proving that chromosomal genes have role in fungal antagonism.
In the present investigation, there was variation in the ability of cured strains in their antagonistic potential towards fungal pathogens, owing either to phase variation, which regulates biocontrol traits (production of antifungal metabolites and biosurfactants) as reported for Pseudomonas spp. strains (35) , or to mutation in the chromosomal genes as a result of incubation in the presence of the curing agent. Antifungal antibiotics of microbial origin, which are synthesized biologically, have been demonstrated not only to have specific activity against the target pathogens but also to be generally biodegradable, thus overcoming the concerns about residual effects of synthetic fungicides. The present study demonstrated the presence of common, well-characterized antibiotic biosynthetic genes in our strain located on the chromosome. Knowledge of the genes that harbor specific biocontrol traits will contribute in improving the efficacy of existing biocontrol agents.
A better understanding of the properties of beneficial agents, and more specifically of the genes conferring the biocontrol potential, would prove useful in both facilitating requirements for registration of such agents and also for improving their salient properties.
